GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP 2.5mg+4mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film-coated tablet contains:
Montelukast Sodium I.P.
equivalent to Montelukast …………………………….10mg
Levocetirizine Dihydrochloride I.P……………………………5mg
Excipients…………………………………. q.s.
Colours: Sunset Yellow FCF
B. Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP 2.5mg+4mg
Each film-coated tablet contains:
Montelukast Sodium
equivalent to Montelukast…………………………….2.5mg
Levocetirizine Hydrochloride……………………………5mg
Excipients…………………………………. q.s.
Colours: Quinoline Yellow
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
Read enclosed leaflet before use.
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
STORAGE & DOSAGE:
Do not freeze.
Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.
Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP 10mg+5mg Technical Specification:
Product Name: | Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP 10mg+5mg |
Brand Name: | Montutaj-LC |
Strength: | (10mg+5mg), (2.5mg+4mg) |
Dosage Form: | Tablet (film-coated) |
Route of Administration: | Via oral Route |
Packing: | 10s, 30s, 100s |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
Regulatory Documents: | COA, MOA, Stability Studies, GMP |
Therapeutic use: | Antiallergic |
Indication: | Combination therapy (montelukast + levocetirizine) is a more effective strategy than monotherapy in the treatment of persistent allergic rhinitis. |
Storage: | Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP 10mg+5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP 10mg+5mg
Each film-coated tablet contains:
Montelukast Sodium I.P.
equivalent to Montelukast …………………………….10mg
Levocetirizine Dihydrochloride I.P……………………………5mg
Excipients…………………………………. q.s.
Colours: Sunset Yellow FCF
THERAPEUTIC INDICATIONS:
It’s usually prescribed when asthma is mild and can stop it from getting worse. It can also help people with asthma who have breathing difficulties when they exercise (exercise-induced asthma) and seasonal allergies, such as sneezing, itchiness and a blocked or runny nose (allergic rhinitis).
CAUTION & SCHEDULE :
CAUTION: SWALLOW WHOLE DO NOT CHEW OR CRUSH
Read enclosed leaflet before use.
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
STORAGE & DOSAGE:
Storage: Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.